These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 12753749)

  • 1. Polyethylene glycol-coated liposomes for oral delivery of recombinant human epidermal growth factor.
    Li H; Song JH; Park JS; Han K
    Int J Pharm; 2003 Jun; 258(1-2):11-9. PubMed ID: 12753749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multivesicular liposomes for oral delivery of recombinant human epidermal growth factor.
    Li H; An JH; Park JS; Han K
    Arch Pharm Res; 2005 Aug; 28(8):988-94. PubMed ID: 16178428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and evaluation of poly(L-lactic acid) microspheres containing rhEGF for chronic gastric ulcer healing.
    Han K; Lee KD; Gao ZG; Park JS
    J Control Release; 2001 Aug; 75(3):259-69. PubMed ID: 11489314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and evaluation of a folic acid receptor-targeted oral vancomycin liposomal dosage form.
    Anderson KE; Eliot LA; Stevenson BR; Rogers JA
    Pharm Res; 2001 Mar; 18(3):316-22. PubMed ID: 11442271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of redispersible liposomal dry powder using an ultrasonic spray freeze-drying technique for transdermal delivery of human epithelial growth factor.
    Yin F; Guo S; Gan Y; Zhang X
    Int J Nanomedicine; 2014; 9():1665-76. PubMed ID: 24729702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human epidermal growth factor-loaded liposomes and transferosomes for dermal delivery: Development, characterization, and cytotoxicity evaluation.
    Doustvaghe YK; Haeri A; Sisakht MM; Amirkhani MA; Vatanpour H
    Drug Dev Res; 2024 Aug; 85(5):e22234. PubMed ID: 39041350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of molecular size of PEGylated recombinant human epidermal growth factor on the biological activity and stability in rat wound tissue.
    Hee Na D; Seok Youn Y; Bok Lee I; Ji Park E; Jeon Park C; Choon Lee K
    Pharm Dev Technol; 2006; 11(4):513-9. PubMed ID: 17101522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of excipients on the stability and transport of recombinant human epidermal growth factor (rhEGF) across Caco-2 cell monolayers.
    Kim IW; Yoo HJ; Song IS; Chung YB; Moon DC; Chung SJ; Shim CK
    Arch Pharm Res; 2003 Apr; 26(4):330-7. PubMed ID: 12735693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Buccal mucosal ulcer healing effect of rhEGF/Eudispert hv hydrogel.
    Park JS; Yoon JI; Li H; Moon DC; Han K
    Arch Pharm Res; 2003 Aug; 26(8):659-65. PubMed ID: 12967203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanotechnology promotes the full-thickness diabetic wound healing effect of recombinant human epidermal growth factor in diabetic rats.
    Chu Y; Yu D; Wang P; Xu J; Li D; Ding M
    Wound Repair Regen; 2010; 18(5):499-505. PubMed ID: 20840519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced percutaneous delivery of recombinant human epidermal growth factor employing nano-liposome system.
    Jeon SO; Hwang HJ; Oh DH; Seo JE; Chun KH; Hong SM; Kim MJ; Kim WC; Park MS; Yoon CH; Min KH; Suh CW; Lee S
    J Microencapsul; 2012; 29(3):234-41. PubMed ID: 22214321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pegylated recombinant human epidermal growth factor (rhEGF) for sustained release from biodegradable PLGA microspheres.
    Kim TH; Lee H; Park TG
    Biomaterials; 2002 Jun; 23(11):2311-7. PubMed ID: 12013178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. rhEGF microsphere formulation and in vitro skin evaluation.
    Al Haushey L; Bolzinger MA; Fessi H; Briançon S
    J Microencapsul; 2010; 27(1):14-24. PubMed ID: 19212891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. rhEGF-containing thermosensitive and mucoadhesive polymeric sol-gel for endoscopic treatment of gastric ulcer and bleeding.
    Maeng JH; So JW; Kim J; Kim IA; Jung JH; Min K; Lee DH; Yang SG
    J Biomater Appl; 2014 Mar; 28(7):1113-21. PubMed ID: 23942163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of hydrogel embedded polymer-growth factor conjugated nanoparticles as a diabetic wound dressing.
    Hajimiri M; Shahverdi S; Esfandiari MA; Larijani B; Atyabi F; Rajabiani A; Dehpour AR; Amini M; Dinarvand R
    Drug Dev Ind Pharm; 2016 May; 42(5):707-719. PubMed ID: 26266962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of surface charge, particle size, and modification by polyethylene glycol of liposomes on their association with Caco-2 cells across an unstirred water layer.
    Kono Y; Iwasaki A; Fujita T
    Pharmazie; 2018 Jan; 73(1):3-8. PubMed ID: 29441943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability Studies of a Freeze-Dried Recombinant Human Epidermal Growth Factor Formulation for Wound Healing.
    Santana H; García G; Vega M; Beldarraín A; Páez R
    PDA J Pharm Sci Technol; 2015; 69(3):399-416. PubMed ID: 26048746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A comparative study on burn wound healing treated by different methods of recombinant human epidermal growth factor].
    Liao Y; Guo L; Ding EY
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2003 Jul; 17(4):301-2. PubMed ID: 12920719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced systemic exposure of fexofenadine via the intranasal administration of chitosan-coated liposome.
    Qiang F; Shin HJ; Lee BJ; Han HK
    Int J Pharm; 2012 Jul; 430(1-2):161-6. PubMed ID: 22525082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transport of epidermal growth factor in the stroke-injured brain.
    Wang Y; Cooke MJ; Lapitsky Y; Wylie RG; Sachewsky N; Corbett D; Morshead CM; Shoichet MS
    J Control Release; 2011 Feb; 149(3):225-35. PubMed ID: 21035512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.